GLP-1 receptor agonist peptide gastrin conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9259477
SERIAL NO

14355906

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates, inter alia, to certain peptide conjugates, and to the use of the conjugates in the treatment of a variety of diseases or disorders, including diabetes (type 1 and/or type 2) and diabetes-related diseases or disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEALAND PHARMA A/SSMEDELAND 36 GLOSTRUP DK-2600

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Østerlund, Torben Lund, SE 10 130
Almholt, Dorthe Lennert Christensen Greve, DK 2 31
Fosgerau, Keld Rødovre, DK 13 258
Larsen, Lone Frost Charlottenlund, DK 2 31
Neerup, Trine Skovlund Ryge Frederikssund, DK 7 181
Tolborg, Jakob Lind Herlev, DK 22 424

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00